- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
益肺灵方干预治肺动脉高压气虚血瘀证的临床研究
Clinical Study on Intervention and Treatment of Qi-deficiency-
blood-stasis syndrome in Pulmonary Hypertension By Yifeiling
Prescription
Speciality: Internal Medicine of TCM
Author: Tian Xia
Tutor: Professor Cao Bin
Abstract
Objective: To investigate the symptom modifying and ultrasonic change of
Qi-deficiency-blood-stasis syndrome in pulmonary hypertension by Yifeiling prescription.
By detecting the indexes that the patients cured the front and back, such as clinical
symptom scores, PASP and cardiac function, to explore its c1inical value. Methods:60
patients diagnosed Qi-deficiency-blood-stasis syndrome in pulmonary hypertension were
randomly classified into two groups.30 patients were treated with Sildenafil and Yifeiling
prescription in treated group,others were treated with Sildenafil and placebo in control
group.All of the groups were treated four 12 weeks as a course,taken for 1 courses. Results:
Treatment group could improve the patients’ clinical symptoms and signs, and the effects
were better than control group (p0.05).In the sides of improvement of echocardiography ,
exercise tolerance,cardiac function and so on,the effects of treatment group were better
than control group (P0.05). And that there had been no adverse reaction in the course of
treatment. Conclusion:Clinical observation had proved Yifeiling prescription can
significantly improve the patients clinical symptoms,echocardiography , exercise
tolerance , cardiac function.It is an effective prevention and treatment of
Qi-deficiency-blood-stasis syndrome in pulmonary hypertension . It is worth studying
deeply and developing further.
Key Words Pulmonary Hypertension ;Qi
您可能关注的文档
- 活血利水通腑汤疗缺血性中风急性期痰热腑实型的临床研究.pdf
- 活血利水中药联阿托伐他汀钙对颈动脉粥样硬化血管内皮功能的干预研究.pdf
- 活血化瘀利水中复方协同西药治疗慢性心衰的临床研究.pdf
- 活血利湿汤治疗湿血瘀型多囊卵巢综合征的临床观察.pdf
- 活血利湿法配合同剂量的纤溶酶治疗急性期下肢深静脉血栓形成临床观察.pdf
- 活血化瘀法改善发性支气管肺癌高凝状态的临床观察.pdf
- 活血化瘀药治疗核性胸腔积液疗效观察.pdf
- 活血化瘀法治疗常型血瘀型银屑病临床疗效观察及对血液流变学影响的研究.pdf
- 活血息风化痰方疗缺血性中风恢复期风痰瘀阻证的临床观察.pdf
- 活血止痛散外洗疗急性踝关节损伤的临床与实验研究.pdf
- 2025至2030中国生物可吸收支架行业产业运行态势及投资规划深度研究报告.docx
- 2025至2030中国板材行业项目调研及市场前景预测评估报告.docx
- 2025至2030中国骨科植入器材行业市场运行分析及竞争格局与投资发展报告.docx
- 2025至2030中国金葱粉行业项目调研及市场前景预测评估报告.docx
- 2025至2030中国锂离子蓄电池行业市场深度调研及竞争格局与发展趋势分析与未来投资战略咨询研究报告.docx
- 2025至2030中国哌唑替芬行业发展趋势分析与未来投资战略咨询研究报告.docx
- 2025至2030中国家庭室外害虫防治装置行业发展趋势分析与未来投资战略咨询研究报告.docx
- 2025至2030中国预充式注射笔行业现状调查及投资风险预警报告.docx
- 2025至2030中国火焰监测仪行业项目调研及市场前景预测评估报告.docx
- 2025至2030高端红酒行业产业运行态势及投资规划深度研究报告.docx
文档评论(0)